To start your customized experience click the start button
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Angelica Welch
Checkpoint inhibitors in combination with PARP inhibitors are garnering interest, with the impact of PARP inhibitors already well established in this tumor type.
William Goeren, LCSW-R, ACSW, OSW-C, BCD, CancerCare
Getting a second opinion after a cancer diagnosis is considered a routine, essential and necessary component of one’s health care plan, but many people are reluctant to seek one. 
Beth Fand Incollingo
Can a certain diet improve cancer outcomes?
Brielle Urciuoli
Overall, about a fourth of people have taken measures to decrease the cost of their or their loved one’s treatment — even if that means a negative impact on its effectiveness.
Mindy Waizer
Have you ever been criticized for cancer-related accommodations because you look better than you feel?
Kristie L. Kahl
Physicians at Penn Medicine’s Abramson Cancer Center in Philadelphia are ready to launch their new treatment program designed to help patients with cancer to quit smoking. The program is intended to provide patients with “state-of-the-science” tobacco use treatment, while also assisting patients with their medical treatment and recovery.
Beth Fand Incollingo
Immunotherapies are largely unavailable to patients with brain cancer, but many of these approaches are being studied both in labs and in clinical trials, and there is hope that they will eventually play a role in the treatment of gliomas.
Beth Fand Incollingo
Quality-of-life care has benefits from the outset for these patients, but because some might confuse it with end-of-life support, neuro-oncologists may be hesitant about introducing it.
Katie Kosko
A recent study found that the cost to patients with breast, lung and colorectal cancers treated in the hospital outpatient setting was nearly $8,000 more than those treated in the community setting.
Kristie L. Kahl
Data from a pilot study showed an added benefit from the incorporation of extra virgin olive oil into the diets of men with low-risk prostate cancer. As a result, this dietary modification could lead to weight loss, while also helping the body to absorb compounds with anticancer properties.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable